Cronos Group Inc. (CRON) stock
CRONNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 15/306% below fair value
$3.41−0.04 (-1.16%)
Close on Nov 12, 2026Market cap $1.26BP/E 20.1Yield –
Cronos statistics
96 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- Feb 25, 2027 (estimated, before the open)
- Last ex-dividend date
- No dividends
- Fundamentals through
- Sep 30, 2026
- Share price as of
- Nov 12, 2026
Valuation ratiosIndustry
- P/TBV Ratio
- 1.26
- 2.29
- P/OCF Ratio
- 15.49
- 12.93
Enterprise valuationIndustry
- EV / Sales
- 2.75
- 2.60
- EV / EBIT
- 79.96
- 18.72
- EV / FCF
- 8.68
- 22.07
Share statisticsIndustry
- Shares Change (YoY)
- -2.80%
- 10.9%
- Shares Change (QoQ)
- -0.86%
- 0.48%
- Float
- 343M
- 49M
- Shares Held by Insiders
- 6.96%
- 12.1%
- Shares Held by Institutions
- 12.9%
- 56.4%
Short sellingIndustry
- Short Interest
- 4M
- –
- Short Interest Change
- 4.87%
- -0.76%
- Short % of Float
- 1.21%
- 9.06%
- Short % of Shares Outstanding
- 1.13%
- 6.30%
- Days to Cover
- 4.94
- 5.13
Stock price statisticsIndustry
- 52-Week High
- $3.91
- –
- 52-Week Low
- $2.28
- –
- 20-Day Moving Average
- $3.40
- –
- 50-Day Moving Average
- $3.32
- –
- 200-Day Moving Average
- $2.89
- –
- Average True Range (14)
- $0.13
- –
- Price Change (1 Week)
- -8.33%
- 1.51%
- Price Change (1 Month)
- 7.91%
- -2.37%
- Price Change (3 Months)
- 8.60%
- -21.1%
- Price Change (6 Months)
- 24.5%
- -22.8%
- Price Change (YTD)
- 29.7%
- -22.6%
- Price Change (1 Year)
- 35.3%
- -21.0%
- Price Change (3 Years)
- 69.7%
- -24.8%
- Price Change (5 Years)
- -45.5%
- -76.9%
- Average Volume (10 Days)
- 2M
- –
- Average Volume (20 Days)
- 1M
- –
- Average Volume (90 Days)
- 1M
- –
- Relative Volume
- 0.84
- 0.80
- Relative Strength Index (14)
- 51.3
- 44.7
- Volatility (1 Year)
- 40.4%
- 80.2%
- Beta (5 Years)
- 0.85
- 1.07
MarginsIndustry
- Pretax Margin
- 29.2%
- -11.8%
- EBITDA Margin
- 7.38%
- -27.7%
- FCF Margin
- 31.7%
- -8.85%
Returns on capitalIndustry
- Return on Equity (ROE)
- 5.37%
- -51.3%
- Return on Assets (ROA)
- 4.87%
- -40.7%
- Return on Invested Capital (ROIC)
- 2.41%
- -32.9%
- Return on Capital Employed (ROCE)
- 0.63%
- -38.1%
Financial positionIndustry
- Current Ratio
- 12.71
- 3.31
- Quick Ratio
- 11.62
- 2.41
GrowthIndustry
- Revenue Growth (YoY)
- 55.8%
- 7.26%
- Net Income Growth (YoY)
- 60.2%
- -14.4%
- EPS Growth (YoY)
- 70.0%
- -11.7%
- Revenue Growth (3Y CAGR)
- 19.1%
- 2.25%
- Revenue Growth (5Y CAGR)
- 25.7%
- 6.41%
EfficiencyIndustry
- Asset Turnover
- 0.17
- 0.40
- Inventory Turnover
- 2.14
- 2.73
- Revenue Per Employee
- $338.03K
- $429.38K
- Profits Per Employee
- $94.80K
- -$683.67K
- Employee Count
- 610
- 75
- WACC
- 9.14%
- 10.0%
Income statement (TTM)Industry
- Pretax Income
- $60.19M
- -$13.23M
Balance sheetIndustry
- Net Cash (Debt)
- $741.17M
- $16.98M
- Net Cash Per Share
- $2.01
- $0.72
- Equity (Book Value)
- $1.07B
- $52.68M
- Book Value Per Share
- $2.91
- $1.50
- Tangible Book Value
- $1.00B
- $26.74M
- Working Capital
- $791.71M
- $78.52M
Cash flow (TTM)Industry
- Capital Expenditures
- -$15.70M
- -$944.00K
- FCF Per Share
- $0.18
- -$0.42
Dividends and yieldsIndustry
- Earnings Yield
- 4.60%
- -21.0%
- FCF Yield
- 5.20%
- -9.44%
- Buyback Yield
- 3.70%
- -0.73%
- Shareholder Yield
- 3.70%
- 0.00%
Taxes and interestIndustry
- Income Tax
- -$8.52M
- $74.00K
- Effective Tax Rate
- -14.2%
- 20.9%
Scores and fair valueIndustry
- Graham Number
- $3.34
- $19.34
- Graham Upside
- -2.17%
- -46.3%
- Altman Z-Score
- 11.85
- 0.26
- Piotroski F-Score
- 7
- 4
- Beneish M-Score
- -1.87
- -2.62
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 12, 2026. The S&P 500 is measured by the SPY fund.
| Period | CRON | S&P 500 | Difference | CRON per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | +6.2% | -2.7% | +8.9 pts | ||
| 3 months | +7.6% | -1.7% | +9.3 pts | ||
| Year to date | +29.7% | +11.9% | +17.8 pts | ||
| 1 year | +34.3% | +12.0% | +22.3 pts | ||
| 3 years | +65.5% | +78.2% | −12.6 pts | +18.3% | +21.2% |
| 5 years | -45.5% | +73.2% | −118.8 pts | -11.4% | +11.6% |
| 10 years | +34000.0% | +309.6% | +33690.4 pts | +79.2% | +15.1% |
Short interest
Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.
4M CRON shares were sold short on Oct 30, 2026, up 4.9% from the previous report, or 1.21% of the shares available to trade. At recent volumes it would take 4.9 days to buy them back. Over the last 20 sessions, 32.2% of the volume reported to FINRA was short selling.
| Settlement date | Shares short | Change | Avg. daily volume | Days to cover |
|---|---|---|---|---|
| Oct 30, 2026 | 4,151,803 | +4.9% | 840,271 | 4.9 |
| Oct 15, 2026 | 3,958,994 | +17.5% | 834,004 | 4.8 |
| Sep 30, 2026 | 3,368,561 | +3.5% | 896,120 | 3.8 |
| Sep 15, 2026 | 3,253,266 | +0.3% | 790,987 | 4.1 |
| Aug 31, 2026 | 3,244,726 | -4.0% | 1,515,483 | 2.1 |
| Aug 14, 2026 | 3,380,082 | -1.2% | 1,900,049 | 1.8 |
| Jul 31, 2026 | 3,420,140 | -2.2% | 865,814 | 4.0 |
| Jul 15, 2026 | 3,498,092 | +11.5% | 778,120 | 4.5 |
| Jun 30, 2026 | 3,138,220 | -14.8% | 978,598 | 3.2 |
| Jun 15, 2026 | 3,684,956 | +4.0% | 1,217,356 | 3.0 |
| May 29, 2026 | 3,542,205 | -11.8% | 1,243,512 | 2.9 |
| May 15, 2026 | 4,016,383 | -9.5% | 1,761,507 | 2.3 |
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.
See a number that looks wrong?